Bandingkan Harga & Kinerja Kalbe Farma Tbk (KLBF) vs Destinasi Tirta Nusantara Tbk (PDES)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kalbe Farma Tbk dan Destinasi Tirta Nusantara Tbk: Kalbe Farma Tbk diperdagangkan di Rp720 (kapitalisasi pasar 33 T, volume 24 jam 98,44 jt), sedangkan Destinasi Tirta Nusantara Tbk diperdagangkan di Rp404 (kapitalisasi pasar 290,29 M, volume 24 jam 1,2 rb). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 113,7× kapitalisasi pasar Destinasi Tirta Nusantara Tbk, dan Kalbe Farma Tbk lebih aktif diperdagangkan (98,44 jt vs 1,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | PDES | |
|---|---|---|
Kapitalisasi Pasar | 33 T | 290,29 M |
Volume | 98,44 jt | 1,2 rb |
Lot | 984,38 rb | 12 |
Perputaran | 70,64 M | 482,8 rb |
Harga Rata-rata | 717,58 | 402,33 |
Nilai Transaksi | 70,64 M | 482,8 rb |
Harga Ekuilibrium Indikatif | 720 | 404 |
Volume Ekuilibrium Indikatif | 43,62 rb | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →Tentang Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Selengkapnya di halaman PDES →
